Clinical Presentations of Neurosarcoidosis
Neurosarcoidosis presents with a diverse spectrum of neurological manifestations affecting any portion of the nervous system, most commonly cranial neuropathies (particularly facial nerve palsy), followed by aseptic meningitis, optic neuritis, CNS mass lesions, hydrocephalus, and encephalopathy/psychosis. 1
Epidemiology and Significance
Symptomatic neurosarcoidosis occurs in 5-20% of patients with sarcoidosis 1. While most sarcoidosis deaths result from pulmonary disease, neurosarcoidosis represents an important cause of mortality and notably occurs at a younger age than other sarcoidosis-related deaths 1. The clinical manifestations have a significant deleterious impact on quality of life 1.
Anatomical Distribution
Neurosarcoidosis can affect:
- Cranial nerves (most common)
- Brain parenchyma
- Leptomeninges
- Peripheral nerves
- Spinal cord
Specific Clinical Manifestations
Cranial Neuropathies
Cranial nerve abnormalities represent the most common clinical presentation 2:
- Facial nerve palsy - the most prevalent cranial neuropathy (35.7% in one series) 3
- Optic neuritis - associated with particularly poor prognosis for visual recovery 2
- Lower cranial nerve involvement - generally has more favorable outcomes 2
Central Nervous System Presentations
Meningeal involvement:
- Chronic aseptic meningitis
- Leptomeningeal enhancement on imaging 1
Parenchymal disease:
- CNS granulomatous mass lesions with serious sequelae
- T2 hyperintense parenchymal lesions (most common imaging finding) 2
- Seizures
- Encephalopathy/psychosis 1
Structural complications:
- Hydrocephalus
- Increased intracranial pressure from mass effect 4
Spinal cord involvement:
- Myelopathy
- Potential for cord compression 4
Peripheral Nervous System
- Peripheral neuropathy
- Myopathy 1
Neuroendocrine Dysfunction
- Hypothalamic-pituitary axis involvement
- Requires specific management beyond anti-granulomatous therapy 4
Neuropsychiatric Symptoms
Diagnostic Challenges
Critical pitfall: Neurologic problems developing in sarcoidosis patients should not be automatically assumed to represent neurosarcoidosis, as they are often attributable to another cause 4. The heterogeneity of presentations frequently leads to diagnostic delays and complications 6.
The clinical presentations are highly varied and frequently nonspecific, making neurosarcoidosis a clinical challenge to diagnose 2, 7. Distinguishing neurosarcoidosis from mimicking conditions, particularly multiple sclerosis, is especially important 5, 6.
Imaging Patterns
Most common MRI findings:
- T2 hyperintense parenchymal lesions (most frequent)
- Meningeal enhancement (second most common)
- Gadolinium-enhanced MRI is the most sensitive test 4, 2
Clinical Course and Prognosis
The disease demonstrates high morbidity, with only one-third of patients achieving symptom-free status after treatment 8. Specific presentations carry different prognostic implications:
- Optic nerve involvement: Poor prognosis for visual recovery
- Isolated lower cranial nerve involvement: More favorable outcome
- Facial palsy: Most common but variable outcomes 2, 3
The majority of patients (85.7% in one series) show stable disease or improvement with treatment, though mortality and severe morbidity remain significant risks 3.